Title: Myeloablative radioimmunotherapy with Re-188-anti-CD66-antibody for conditioning of high-risk leukemia patients prior to stem cell transplantation: Biodistribution, biokinetics and immediate toxicities
Authors: Buchmann, I ×
Bunjes, D
Kotzerke, L
Martin, H
Glatting, G
Seitz, U
Rattat, Dirk
Buck, A
Dohner, H
Reske, SN #
Issue Date: Apr-2002
Publisher: Mary ann liebert inc publ
Series Title: Cancer biotherapy and radiopharmaceuticals vol:17 issue:2 pages:151-163
Abstract: Background. Stein cell transplantation (SCT) is potentially curative for high-risk leukemia patients. Conditioning regimens affect relapse rate and treatment-related mortality. We evaluated biodistribution, radiation absorbed organ doses and immediate toxicities of myeloablative radioimmunotherapy with marrow selective (188)rhenium (Re-188)-labeled anti-CD66 monoclonal antibody (mAb).
ISSN: 1084-9785
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Non-KU Leuven Association publications
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science